Clinical Trials Logo

Performance clinical trials

View clinical trials related to Performance.

Filter by:

NCT ID: NCT04405531 Completed - Fatigue Clinical Trials

Effects of TOT on Performance, Independence and Fatigue in Children With Cancer

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

This study aims to explore the effects of Task-Oriented Training (TOT) on occupational performance, activities of daily living and fatigue of children in pediatric oncology clinic. Hypothesis: There is no effect of TOT on occupational performance and satisfaction in children with childhood cancer. There is no effect of TOT on functional independence in daily living activities in children with childhood cancer. There is no effect of TOT on fatigue levels in children with childhood cancer.

NCT ID: NCT04298151 Completed - Performance Clinical Trials

Clinical Performance of Zirconia Reinforced GI Versus Conventional Viscous GI in Geriatric Patients

Start date: September 1, 2021
Phase: Phase 2
Study type: Interventional

This study is conducted to evaluate the clinical performance of Zirconomer Improved GI restoration compared to Conventional viscous GI restoration in geriatric patients with Posterior carious lesions in class I or II cavities

NCT ID: NCT04241991 Completed - Aged Clinical Trials

Photobiomodulation (PBM) Therapy on Muscle Performance in Elderly Women

Start date: November 1, 2019
Phase: N/A
Study type: Interventional

The present project aims to investigate the acute and chronic effects of laser photobiomodulation (PBM) at 808 nm on muscle performance in physically active elderly women. The hypothesis of this study is that laser PBM would improve muscle strength (i.e., MVIC and 1RM) and endurance (i.e., repetitions-to-failure, blood lactate levels), functional capacity (i.e., short physical performance battery score), and rating of perceived exertion when compared with placebo laser.

NCT ID: NCT04128449 Completed - Performance Clinical Trials

Modifications in the Anaerob Threshold in Cyclists by Consuming Docosahexaenoic Acid (DHA)

MATCY
Start date: April 1, 2018
Phase: N/A
Study type: Interventional

In a double-blind, parallel randomized clinical trial with 38 cyclists in whom the performance improvement was determined after the consumption of docosahexaenoic acid for one month.

NCT ID: NCT03934762 Completed - Performance Clinical Trials

Aloe Vera Ointment Application and Skeletal Muscle Recovery

Start date: April 25, 2019
Phase: N/A
Study type: Interventional

Aloe vera, sometimes described as pharmaceutical aloe, is a flowering succulent plant with many therapeutic properties such as wound and burn wound healing, treatment of diabetes and reduction of blood lipid profile. These benefits have been primary attributed to its high content in polysaccharides, anthraquinones and lectins. However, aloe vera includes more than 200 ingredients and nutrients (i.e. vitamins, saponins, amino acids, anthraquinones, minerals and trace-elements, salicylic acid, saccharides, lignin, enzymes, sterols) the combination of which offers more powerful effects and health-related benefits compared to each one of them separately. Thus, based on the ingredients and nutrients included, it has been proposed that aloe vera may also offer anti-inflammatory, antioxidative, analgesic and anabolic benefits. Exercise training, especially when it is unaccustomed or characterized by increased intensity, results in skeletal muscle microtrauma accompanied by elevated plasma levels of Creatine Kinase (CK), increased sensation of muscle soreness (DOMS), reduced force generating capacity and marked declines in speed and agility. Both anti-inflammatory and antioxidative mechanisms in skeletal muscle are crucial for the termination of inflammatory response and muscle healing process following exercise-induced aseptic muscle injury and inflammation. Although, it has been proposed that ale vera may elicit anti-inflammatory and antioxidative activity, its effectiveness in alleviating exercise-induced skeletal muscle injury and its symptoms, has not been investigated yet. Therefore, the aim of the present pilot study is to examine the effect of transdermal aloe veral delivery on skeletal muscle damage symptoms following an intense eccentric exercise protocol.

NCT ID: NCT03860766 Completed - Performance Clinical Trials

Photobiomodulation in Different Doses on Strength Capacities and Functional Performance

Start date: July 8, 2020
Phase: N/A
Study type: Interventional

Background: Photobiomodulation has been explored for years, with wide clinical use for wound healing and analgesia in varied orthopedic conditions, but the number of research and clinical use has increased during the last decade. Furthermore, considering the performance, the current literature is conflicting and restricted, with divergences in wavelength, power and energy density applied. Therefore, analyze different doses for a answer in short and long time, associated with capacities of strength, fatigue resistance and functional performance of handball players and healthy individuals becomes necessary. Objective: To analyze the effects of the application of LED photobiomodulation on the capacities of strength, functional efficiency, temperature and fatigue resistance of handball players and healthy individuals. Method: The study sample will be composed of 56 male individuals randomly allocated into four groups: LED 50J (G-50J), LED 240J (G-240J), LED 50-240J (G-50-240J) - progressive dose and Sham (G-S). The volunteers will be submitted to an evaluation of muscle performance and functional performance, metabolic, and physiological evaluation. After initial tests, in five consecutive weeks, the LEDT (940nm - infrared) will be applied to the quadriceps femoris muscle and hamstrings, bilaterally, associated with a muscle strength protocol. After 24 hours of the last application TLED, the tests will be repeated. Seven days after the last intervention will be performed a follow-up. For analysis, normality tests will be used to verify the distribution and adequate statistical tests for the appropriate intra and intergroup comparisons, being considered two factors in the comparisons, time, and group. A significance level of 5% will be adopted.

NCT ID: NCT03832972 Completed - Performance Clinical Trials

Performance During Menstrual Cycle

Start date: October 1, 2018
Phase:
Study type: Observational

This project aims to investigate if muscle strength and muscle power fluctuate during the menstrual cycle. The hypothesis is that the greatest performance will be measured right before ovulation, and at it's lowest on day 1 and 2 of the menstrual cycle in women not using any form for hormonal protection. And that the performance in women using birth control pills, not will variated in the period where they are taking pills (day 1-21).

NCT ID: NCT03759951 Completed - Body Composition Clinical Trials

Hybrid Exercise Training for Health, Performance and Well-Being (DoIT II)

Start date: July 1, 2019
Phase: N/A
Study type: Interventional

Observing a lack of research investigating the chronic physiological and psychological responses to this type of exercise training the aim of this study is to investigate the optimal training configurations of DoIT to produce positive effects on health, performance and quality of life markers in sedentary overweight or obese adults aged 30-55 years. The DoIT program will be performed in a small-group setting indoor or outdoor implementing a progressive manner for 12 months and using bodyweight exercises with alternative modes.

NCT ID: NCT03589612 Completed - Clinical trials for Duchenne Muscular Dystrophy

Regression of Hamstring Flexibility and Performance in Children With Duchenne Muscular Dystrophy

Start date: March 8, 2018
Phase:
Study type: Observational

Investigator investigated that regression of hamstring flexibility and performance in children with Duchenne Muscular Dystrophy.

NCT ID: NCT03561337 Completed - Nutrition Clinical Trials

Nutrient Supplementation Influences Mitochondria Adaptation

Start date: October 1, 2013
Phase: N/A
Study type: Interventional

Twenty-four well trained runners (VO2max 60.73.7 ml O2 Kg-1 min1) completed a six week block randomized controlled intervention period. Subjects were randomly assigned to either PRO-CHO or CHO and matched in pairs for gender, age, VO2max, training and performance status. The PRO- CHO group ingested a protein beverage (0.3g kg-1) before and protein-carbohydrate beverage (0.3g protein kg-1 and 0.1g carbohydrate kg-1) after each exercise session. The CHO group ingested energy matched carbohydrate. Post-absorptive muscle biopsies were obtained pre and post intervention for analysis HAD, CS and PGC-1. Subjects completed two physical tests 6 km performance test (pre, week 1 and week 6) and aVo2max test (pre and post intervention).